text.skipToContent text.skipToNavigation

Are you up to date on the latest anti-Parkinsonian reference standards?

Monday 11 April 2016 is World Parkinson’s Day. According to the Parkinson’s Disease Foundation, an estimated seven to ten million people worldwide are living with Parkinson's disease, a chronic and progressive movement disorder, meaning that symptoms continue and worsen over time.

The cause is unknown, and although there is presently no cure, there are treatment options such as medication and surgery to manage its symptoms.

To support pharmaceutical manufacturers in the development of medication, LGC provides an expanding range of reference materials related to dopamine level management. Popular API families in our range include Levodopa, Carbidopa, Benserazide, Selegiline, Entacapone, Tolcapone, Ropinirole, Pramipexole, Apomorphine, Amantadine and Bromocriptine Mesilate.

View the list with all APIs and impurities >>

View all blog entries >>

print icon Print view


Refine your


Online Ordering made easy


Sign up to our email newsletter



Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.